IBEX 35
10.971,60 -56,20 (-0,51%) Euro Stoxx 50
4.936,90 -52,98 (-1,06%) Dólar/Euro
1,0715 +0,0014 (+0,13%) Petróleo Brent
87,66 -0,36 (-0,41%) Oro
2.346,10 +7,70 (+0,33%) Bitcoin EUR
59.243,47 -1.345,09 (-2,22%)
China Evergrande New Energy Vehicle Group Limited (EVGRF)
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Shawn Siu | Executive Chairman | 24,43k | N/A | 1971 |
| Mr. Yongzhuo Liu | Executive Vice Chairman of the Board | 889,53k | N/A | 1977 |
| Mr. Liyong Qin | Executive Director | 255,85k | N/A | 1978 |
| Mr. Darong Pan | Chief Financial Officer | N/A | N/A | 1973 |
| Mr. Kar Chun Fong | Company Secretary | N/A | N/A | 1975 |
| Mr. Yi Yang | President of Boao Evergrande International Hospital | N/A | N/A | 1963 |
Descripción
China Evergrande New Energy Vehicle Group Limited, an investment holding company, engages in the technology research and development, manufacturing, sales, and servicing of new energy vehicles in the People's Republic of China, Europe, and internationally. The company is involved in the development and sale of vehicle living projects; landscaping business; manufacturing and sale of smart mobility products; design, manufacturing, and sale of power lithium-ion batteries; and research and development, manufacturing, and sale of electric vehicles, as well as wholesale of home care and healthcare products. It also provides technical services; and sells vehicles and vehicle components; and other products. The company was formerly known as Evergrande Health Industry Group Limited and changed its name to China Evergrande New Energy Vehicle Group Limited in August 2020. The company was founded in 1999 and is headquartered in Guangzhou, the People's Republic of China. China Evergrande New Energy Vehicle Group Limited operates as a subsidiary of China Evergrande Group.
Gobierno corporativo
El ISS Governance QualityScore de China Evergrande New Energy Vehicle Group Limited, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
